Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sanofi SA (NASDAQ: SNY ) on Thursday reported second-quarter sales of $13.482 billion (11.597 billion euros), beating the consensus of $12.65 billion. Sales increased 16% year over year, up 17.8% in constant currency. Dupixent Drives Growth While Vaccines Sales Decline Dupixent sales increased by 37.6% to 5.154 billion
Sanofi's multiple sclerosis drug Cenrifki approved in Europe despite FDA rejection
Sanofi secures EU approval for Cenrifki as first disability-targeting medicine for secondary progressive multiple sclerosis without relapses